Sjogren's Syndrome

Sjögren's Syndrome

IVIg Relieves Neuropathy in Primary Sjogren's Syndrome Intravenous immunoglobulin (IVIg) may offer some relief for patients with sensorimotor neuropathy or nonataxic sensory neuropathy associated with primary Sj�gren's syndrome, researchers from France report.
Reuters Health Information, July 1, 2011
Lifetime Risk for RA Much Higher Than Expected Population-based data predict that 1 in 12 women and 1 in 20 men will develop RA or a related disease.
Medscape Medical News, January 31, 2011

Sjogren's Syndrome: An Update on Diagnosis and Management Dr. Robert Fox provides an update on diagnosing and managing Sjogren's Syndrome based on data presented at the 2011 American College of Rheumatology Annual Meeting.
Medscape Rheumatology, January 10, 2012
IVIg For Sjögren Neuropathy: Worth the Price? Could this pricey therapy help treat the neurologic manifestations associated with Sjögren syndrome?
Medscape Rheumatology, October 14, 2011

How to Assess Treatment Efficacy in Sjogren's Syndrome?
Current Opinion in Rheumatology, April 30, 2012
Analysis of Saliva to Distinguish Sjogren's Syndrome
Arthritis Research & Therapy, April 4, 2012
Drug-induced Rheumatic Diseases
Current Opinion in Rheumatology, March 20, 2012
MicroRNAs in Systemic Rheumatic Diseases
Arthritis Research & Therapy, February 1, 2012
Disturbance of Cytokine Networks in Sjogren's Syndrome
Arthritis Research & Therapy, January 25, 2012